ST Segment Depression in 12 lead ECG and Severity of Coronary Artery Disease in Non-ST segment elevation Acute Coronary Syndrome

Miah, Mohammad Emdadul Hoque; Chowdhury, Abul Hussain Khan; Islam, Khandaker Qamrul; Mir, Jamaluddin; Ghafur, Shakil; Khalequzzaman, -; Ullah, Mohammad

doi:10.3329/cardio.v9i2.32422

Cited by 3 publications

(3 citation statements)

References 9 publications

(12 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Troponin I levels are much more elevated with ST depression depth increase 19 .The study was supported by Mia M E H, In 2011 one cross sectional study was done in NICVD, Bangladesh, which found that magnitude of ST-segment depression positively correlate with the severity of coronary artey disease. 20…”

Section: Discussionmentioning

confidence: 99%

Demographic Profile of NSTEMI (Non ST Elevation Myocardial Infarction) Patients & Association of ST-Segment Depression and Level of Troponin I with NSTEMI Patient's In-Hospital Outcome

Zahid¹,

Khan

Chowdhury

et al. 2016

Med. Today

View full text Add to dashboard Cite

Acute coronary syndrome (ACS) remains the leading cause of death in the developed world and second leading cause of death in developing countries. Elevated troponin levels and extent of ST-segment depressions are clinically important because they may act as an effective prognostic marker .This cross-sectional study has been designed to see the correlation of ST-segment depression and level of troponin I with in-hospital outcome of NSTEMI patients. The study was conducted in the Department of Cardiology, Dhaka Medical College Hospital, Dhaka during the period of April, 2011- March, 2012. A total of 90 patients were selected by purposive sampling. In this study,the mean ±SD age of the patients was 55.9±9.1 years with a range of 36-80 years with a male -female ratio of 2:1.Over all dyslipidaemia was the most common risk factor present in 55(61.10%) patients followed by smoking in 48(53.3%) patients then obesity in 32(35.60%) then hypertension in 31(34.4%) patients. Troponin I level was significantly high in patients who developed acute LVF (10.36±7.4 vs 7.0124±6.8, p=.027), and cardiogenic shock (13.72±11.37 vs 8.64±7.35, p=.033). Troponin I was significantly high in patients who developed complication (10.72±8.84 vs 6.24±5.41, p=.005) than the patients who were discharged without complication. ST segment depression was significantly more in patients who developed acute LVF(1.07±1.63 vs.55±.74, p=.048). Logistic regression analysis of acute LVF with Troponin I and ST-segment depression showed that ST-segment depression and level of Troponin I were important correlates of acute LVF .Medicine Today 2015 Vol.27(2): 14-19

show abstract

Section: Discussionmentioning

confidence: 99%

Demographic Profile of NSTEMI (Non ST Elevation Myocardial Infarction) Patients & Association of ST-Segment Depression and Level of Troponin I with NSTEMI Patient's In-Hospital Outcome

Zahid¹,

Khan

Chowdhury

et al. 2016

Med. Today

View full text Add to dashboard Cite

show abstract

“…In 2011 study was conducted one cross sectional study in NICVD, Bangladesh, which found that magnitude of STsegment depression positively correlate with the severity of coronary artery disease. 18 Average left ventricular ejection fraction (LVEF) of the study population was 54.6 ± 7.1. LVEF was decreased in Group I (53.2±6.3) than Group II (56.9±7.1) with statistically significant difference.…”

Section: Discussionmentioning

confidence: 99%

Association of CHA2DS2-VASc-HS Score with Adverse In-hospital Outcomes in Patients with Non-ST Segment Elevation Myocardial Infarction

Bala

Rahman

Ullah³

et al. 2019

Cardiovasc. j.

Self Cite

View full text Add to dashboard Cite

Background: Early detection of patients with non-ST segment elevation myocardial infarction (NSTEMI) who would suffer from adverse in-hospital outcomes is important for the therapeutic decision. Recently it was described that CHA2DS2-VASc-HS and CHA2DS2-VASc score is a predictor for severity and adverse in-hospital outcomes in patients with stable coronary artery disease (CAD) and acute coronary syndrome. The aim of our study was to assess the accuracy of the CHA2DS2-VASc-HS score predicting adverse inhospital outcomes in NSTEMI patients. Methods: 120 patients with NSTEMI were enrolled in this study. The CHA2DS2-VASc-HS score was calculated. The study subjects were divided into two groups. Patients’ with CHA2DS2-VASc-HS score>4 were put into group I and scored” 4 into group II. They were treated as per hospital treatment protocol and followed-up for adverse in-hospital outcomes (Heart failure, cardiogenic shock, recurrent ischemic pain, significant arrhythmia and death). Results: It was observed that, patients with CHA2DS2-VASc-HS score >4 had more adverse in-hospital outcomes than CHA2DS2-VASc-HS score d” 4 (20% vs. 3.3%, p=0.01). Group I patients developed cardiogenic shock 10%, heart failure 4%, recurrent ischemia 11.7%, significant arrhythmia 1.7% and death 1.7% than group II patients (1.7%, 3.3%, 3.3%, 0% and 0% respectively). By risk measurement, CHA2DS2-VASc-HS score >4 emerged as a risk factor for developing adverse in-hospital outcome (Relative risk=6). Conclusion: NSTEMI patients with high CHA2DS2-VASc-HS score have more adverse in-hospital outcomes. This score, which involves only clinical parameters, can be used as a predictor of outcomes in this group of patients. Cardiovasc. j. 2019; 11(2): 159-166

show abstract

“…The degree of STsegment depression is clearly related to the severity of coronary artery disease. [15] The study population average left ventricular ejection fraction (LVEF) was 54.6 ± 7.1. In Group I (53.2±6.3) LVEF dropped from Group II (56.9±7.1) with statistically significant difference.…”

Section: Variables Group I (N= 60) Mean±sdmentioning

confidence: 99%

The value of CHA2DS2-VASc-HS score for prediction of adverse in-hospital outcomes in patients with non-ST segment elevation myocardial infarction

Mahmoud

Kabil

Ebed

et al. 2021

Benha Journal of Applied Sciences

View full text Add to dashboard Cite

For a treatment choice the early identification of non-ST myocardial infarction segment patients (NSTEMI) with poor in-hospital results is essential. The CHA2DS2-VASc-HS and CHA2DS2-VASc score was recently reported as a predictor of severity and poor outcomes in individuals with stable coronary artery disease (CAD) and acute coronary syndrome. Our research aimed at evaluating the precision of the CHA2DS2-VASc-HS score, which predicts poor outcomes in hospitals in NSTEMI patients. 120 NSTEMI patients have been enrolled. The score for CHA2DS2-VASc-HS has been computed. The participants of the research were split into two groups. Group I and Group II score <4 were placed in Patients with CHA2DS2-VASc-HS score>4. Patients with CHA2DS2-VASc-HS >4 were found to have higher unfavourable outcomes in the hospital than the CHA2DS2-VASc-HS score <4.

show abstract

ST Segment Depression in 12 lead ECG and Severity of Coronary Artery Disease in Non-ST segment elevation Acute Coronary Syndrome

Cited by 3 publications

References 9 publications

Demographic Profile of NSTEMI (Non ST Elevation Myocardial Infarction) Patients & Association of ST-Segment Depression and Level of Troponin I with NSTEMI Patient's In-Hospital Outcome

Demographic Profile of NSTEMI (Non ST Elevation Myocardial Infarction) Patients & Association of ST-Segment Depression and Level of Troponin I with NSTEMI Patient's In-Hospital Outcome

Association of CHA2DS2-VASc-HS Score with Adverse In-hospital Outcomes in Patients with Non-ST Segment Elevation Myocardial Infarction

The value of CHA2DS2-VASc-HS score for prediction of adverse in-hospital outcomes in patients with non-ST segment elevation myocardial infarction

Contact Info

Product

Resources

About